International partnerships have always been an important element in PharmEvo’s success and will continue to play a pivotal role in company’s future.

• We plan to develop our business both by Licensing or Acquiring Proprietary / Patented products to market in our part of the world,
  

• By building partnerships with overseas companies for products manufactured by PharmEvo and expanding our operations / developing new markets.

To any prospective partner PharmEvo offers:

• An established and proven Sales and Marketing capability in countries where we operate.
• An aggressive management team and supportive corporate culture committed to partnering.
• A proven product development and regulatory capability.
• A flexible and creative approach to collaborations.
• The ability to respond rapidly to opportunities.

In-licensing:

We are seeking Proprietary, Patented, Generic Plus, and New Drug Delivery Systems products to sell through our established sales, marketing and distribution infrastructure. The main therapy target areas are:

• Anti-Infective, Gastroenterology-Cardiovascular, Endocrinology, CNS, Anti-Histamine, Dermatology, Respiratory, Metabolism, Blood Products, Pain Management, Oncology, Women & Child Health, Probiotics and Biotechnology Products.
  
  
• We are already in agreements with some global HealthCare companies from Europe, Americas and Asia.

International Presence / Export:

As part of our evolving global business aims, we are showing our presence in many countries around the world. PharmEvo holds more than 200 marketing authorizations of its products in overseas markets and number is increasing ever since.

Focused Overseas Markets:

1. South America
2. Central Asian Republics
3. Middle East & Africa
4. Asia, Asia Pacific & Far East

Contact:

Nadeem Rehmat
Director Business Development
Email: nadeem.rehmat@pharmevo.biz
Phone: +92-21-34315195-7